Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Retention and linkage to care news

Show

From To
Impact of side-effects on retention in HIV care is underestimated, African study suggests

The impact of drug side-effects on retention in HIV care is probably being underestimated, according to an interview-based study of people taking antiretroviral treatment and

Published
10 October 2017
By
Keith Alcorn
Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?

The US Centers for Disease Control and Prevention (CDC) used 27 September, National Gay Men’s HIV/AIDS Awareness Day, to announce that HIV diagnoses had fallen in white

Published
03 October 2017
By
Gus Cairns
No new HIV infections among Kaiser PrEP users, but data shows missed opportunities

No new HIV infections have occurred among nearly 5000 people who started Truvada for pre-exposure prophylaxis (PrEP) in the Kaiser Permanente Northern California health system, according to a

Published
07 September 2017
By
Liz Highleyman
Paediatric to adult HIV care transition – the risk of disengagement

Young adults represent a growing proportion of the number of people living with HIV in the USA, but they are at high-risk of disengaging from care when transitioning from paediatric to adult services.

Published
04 September 2017
From
AVERT
For HIV patients fewer clinic visits means better treatment retention, Zambia study finds

Patients receiving care for HIV who were scheduled for clinic visits every six months were less likely to show up late, miss visits, have gaps in treatment, and drop off treatment rolls than patients scheduled every three months, a study in Zambia has shown.

Published
29 August 2017
From
Science Speaks
One in seven people offered PrEP in African study start it immediately

One in seven people (14%) offered pre-exposure prophylaxis (PrEP) in a large community study of enhanced HIV testing and treatment in Kenya and Uganda started

Published
28 August 2017
By
Gus Cairns
Trans women wary of antiretroviral drug and hormone interactions

Transgender women living with HIV may be hesitant to use antiretroviral therapy (ART) or not take it as prescribed because of concerns about drug interactions with feminising hormones,

Published
23 August 2017
By
Liz Highleyman
HIV: MSF concerned by high numbers of AIDS deaths in sub-Saharan Africa

Global attention is needed to prevent and treat AIDS in antiretroviral era, with 50 per cent of hospital admissions in MSF hospitals already on treatment and showing signs of clinical failure.

Published
25 July 2017
From
Médecins Sans Frontières (MSF) International
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to

Published
25 July 2017
By
Keith Alcorn
Less frequent clinic visits for HIV care: fine tuning needed

Shifts to less frequent clinic visits and medication pick-ups to free up healthcare resources and make life easier for people living with HIV are being implemented successfully

Published
24 July 2017
By
Keith Alcorn
← First12345...25Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.